Everhart Financial Group, Inc.
Source: SEC Form 13F · as of Mar 2026Everhart Financial Group, Inc. holds 9 biotech & pharma companies tracked by BioSniper, totaling $6.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
9
Total value held
$6.0M
BioSniper AIPage evidence connected
Prepared research question
What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 11,239 | $1.6M |
| SLSSELLAS Life Sciences Group, Inc. | 364,397 | $1.5M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 2,901 | $960K |
| REGNREGENERON PHARMACEUTICALS, INC. | 660 | $510K |
| INSMINSMED Inc | 2,934 | $480K |
| BMRNBIOMARIN PHARMACEUTICAL INC | 5,211 | $294K |
| ARGXARGENX SE | 384 | $280K |
| IONSIONIS PHARMACEUTICALS INC | 3,470 | $261K |
| ONCYONCOLYTICS BIOTECH INC | 138,161 | $117K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.